Zobrazeno 1 - 10 of 105 pro vyhledávání: '"C. Cazaubon"'
1
Vasopressin Does not Effect Hypertension Caused by Long-Term Nitric Oxide Inhibition
Autor: C. Loichot, Jean-Louis Imbs, C. Cazaubon, D. Nisato, W. De Jong, Mariette Barthelmebs, Michèle Grima
Publikováno v: Hypertension. 35:602-608
Abstract —Nitric oxide attenuates both vasopressin-induced vasoconstriction and vasopressin release. We tested whether hypertension and renal dysfunction elicited by chronic inhibition of nitric oxide (NO) synthesis using N G -nitro- l -arginine (L
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12748623059e8f0d085bc69c32902713
https://doi.org/10.1161/01.hyp.35.2.602
Zobrazit plný text záznamu
2
Are vasopressin peripheral V1receptors involved in the development of malignant hypertension and stroke in SHR-SPs?
Autor: E. Vacher, Dino Nisato, Christine Richer, J. F. Giudicelli, C. Cazaubon, Paul Fornes
Publikováno v: Fundamental & Clinical Pharmacology. 9:469-478
The aim of this study was to determine whether activation of vasopressin (AVP) peripheral V1 receptors is involved in the development of malignant hypertension, stroke, and end-organ damage in stroke-prone spontaneously hypertensive rats (SHR-SPs). F
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f87f7e4ff5eab3399d6eac729166a8
https://doi.org/10.1111/j.1472-8206.1995.tb00522.x
Zobrazit plný text záznamu
3
Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure
Autor: M J, Clair, M K, King, A T, Goldberg, J W, Hendrick, R, Nisato, D M, Gay, A E, Morrison, J H, McElmurray, R S, Krombach, B R, Bond, C, Cazaubon, D, Nisato, F G, Spinale
Publikováno v: The Journal of pharmacology and experimental therapeutics. 293(3)
With developing congestive heart failure (CHF), activation of the vasopressin V(1a) and angiotensin II type 1 (AT(1)) receptors can occur. In the present study, we examined the direct effects of V(1a) receptor blockade (V(1a) block), selective AT(1)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::04dedd7824355bdcf7cb001da57ac8fd
https://pubmed.ncbi.nlm.nih.gov/10869385
Zobrazit plný text záznamu
4
Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats
Autor: Mariette Barthelmebs, Dino Nisato, Cécile Loichot, Jean-Jacques Helwig, W. De Jong, Jean-Louis Imbs, C. Cazaubon
Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology. 361(3)
The renal vascular response to vasopressin and its modulation were evaluated in vivo by infusing the peptide directly into the renal artery of anaesthetized rats. The intra-renal artery (i.r.a) infusion of vasopressin induced a dose-dependent decreas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d86f014b38d36afc3186808a04f5b7c
https://pubmed.ncbi.nlm.nih.gov/10731046
Zobrazit plný text záznamu
5
Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist
Autor: C, Cazaubon, J, Gougat, F, Bousquet, P, Guiraudou, R, Gayraud, C, Lacour, A, Roccon, G, Galindo, G, Barthelemy, B, Gautret
Publikováno v: The Journal of pharmacology and experimental therapeutics. 265(2)
SR 47436, 2-n-butyl-3-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl) methyl]-1,3-diaza-spiro[4,4]non-1-en-4-one, is a new potent and selective AT1 angiotensin II (AII) receptor antagonist. It competitively inhibited [125I]AII binding to AT1 subtype receptors
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b47d1e44b88eac4fe54cf46b1bc803e8
https://pubmed.ncbi.nlm.nih.gov/8496828
Zobrazit plný text záznamu
6
Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients
Autor: T, Denolle, P, Luo, T T, Guyene, C, Cazaubon, J, Sissmann, P, Corvol, J, Ménard
Publikováno v: Arzneimittel-Forschung. 43(2A)
The blood pressure and renin-angiotensin system effects of the new renin inhibitor, SR 43845 ([N-(pyridyl-3-propionyl)-phenylalanyl- histidyl-(3S,4S) ACHPA-isoleucylamino]-2-methyl-2-dihydroxy-1,3-propane), were studied in 12 hypertensive patients on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::991c8970f848c8d0ff8d8a1ba1ce67a5
https://pubmed.ncbi.nlm.nih.gov/8498973
Zobrazit plný text záznamu
8
[A new method for determination of renin inhibitors]
Autor: C, Cazaubon, J P, Richaud, D, Nisato
Publikováno v: Archives des maladies du coeur et des vaisseaux. 83(8)
To determine the concentration of renin inhibitors in plasma or other biological fluids, we developed an original approach to the already existing methods, such as HPLC or radio-inhibitor binding and enzyme inhibitor assays. We made an antigen-antibo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1c3d766fa916ba80dc44307acd6326b7
https://pubmed.ncbi.nlm.nih.gov/2124466
Zobrazit plný text záznamu
9
Système multicapteurs de détection de gaz, portable, utilisant la technique du fenêtrage temporel
Autor: D. Rebiere, C. Bordieu, H. Levi, C. Cazaubon, J. Pistre
Publikováno v: Revue de l'Electricité et de l'Electronique. :55
Un systeme multicapteurs autonome et portable a ete construit. Il peut gerer quatre capteurs de gaz a sortie frequentielle (ondes acoustiques de surface, SAW, par exemple) et quatre capteurs a sortie voltaique (capteurs a oxydes semi-conducteurs, par
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e8b70ae95c443fbbf06c23575629219d
https://doi.org/10.3845/ree.1999.027
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje